Cargando…

Epigallocatechin gallate restores the reduction of protein phosphatase 2 A subunit B caused by middle cerebral artery occlusion

BACKGROUND: Epigallocatechin gallate (EGCG) is a flavonoid compound commonly found in green tea. It exhibits antioxidant, anti-inflammatory, and neuroprotective effects in cerebral ischemia. Protein phosphatase 2 A (PP2A) is an important serine/threonine phosphatase enzyme involved in various cellul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Murad-Ali, Kang, Ju-Bin, Park, Dong-Ju, Koh, Phil Ok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926636/ https://www.ncbi.nlm.nih.gov/pubmed/36782340 http://dx.doi.org/10.1186/s42826-023-00155-6

Ejemplares similares

Epigallocatechin gallate alleviates neuronal cell damage against focal cerebral ischemia in rats
por: PARK, Dong-Ju, et al.
Publicado: (2020)

Quercetin attenuates the reduction of parvalbumin in middle cerebral artery occlusion animal model
por: Park, Dong-Ju, et al.
Publicado: (2021)

Identification of regulated proteins by epigallocatechin gallate treatment in an ischemic cerebral cortex animal model: a proteomics approach
por: PARK, Dong-Ju, et al.
Publicado: (2021)

Retinoic acid regulates the ubiquitin–proteasome system in a middle cerebral artery occlusion animal model
por: Kang, Ju-Bin, et al.
Publicado: (2022)

Hyperglycemia reduces PP2A subunit B expression in a middle cerebral artery occlusion animal model
por: PARK, Dong-Ju, et al.
Publicado: (2017)

Quercetin alleviates the injury-induced decrease of protein phosphatase 2A subunit B in cerebral ischemic animal model and glutamate-exposed HT22 cells
por: PARK, Dong-Ju, et al.
Publicado: (2019)

Hyperglycemia aggravates decrease in alpha-synuclein expression in a middle cerebral artery occlusion model
por: Kang, Ju-Bin, et al.
Publicado: (2018)

Quercetin attenuates neuronal cells damage in a middle cerebral artery occlusion animal model
por: PARK, Dong-Ju, et al.
Publicado: (2018)

Curcumin attenuates the middle cerebral artery occlusion-induced reduction in γ-enolase expression in an animal model
por: Gim, Sang-Ah, et al.
Publicado: (2015)

Quercetin attenuates the injury-induced reduction of γ-enolase expression in a middle cerebral artery occlusion animal model
por: Jeon, Seong-Jun, et al.
Publicado: (2017)

Resveratrol modulates the Akt/GSK-3β signaling pathway in a middle cerebral artery occlusion animal model
por: Park, Dong-Ju, et al.
Publicado: (2019)

Decrease of protein phosphatase 2A subunit B by glutamate exposure in the cerebral cortex of neonatal rats
por: Kang, Ju-Bin, et al.
Publicado: (2020)

Bioaccessibility and Bioavailability of (-)-Epigallocatechin Gallate in the Bread Matrix with Glycemic Reduction
por: Li, Lanqi, et al.
Publicado: (2022)

Curcumin treatment recovery the decrease of protein phosphatase 2A subunit B induced by focal cerebral ischemia in Sprague-Dawley rats
por: Shah, Fawad-Ali, et al.
Publicado: (2015)

Hyperglycemia decreases preoxiredoxin-2 expression in a middle cerebral artery occlusion model
por: Koh, Phil-Ok
Publicado: (2017)

Proteomic Identification of Proteins Differentially Expressed in Response to Resveratrol Treatment in Middle Cerebral Artery Occlusion Stroke Model
por: SHAH, Fawad-Ali, et al.
Publicado: (2014)

Focal Cerebral Ischemia Reduces Protein Phosphatase 2A Subunit B Expression in Brain Tissue and HT22 Cells
por: Koh, Phil-Ok
Publicado: (2011)

Effect of Epigallocatechin Gallate on Viability of Kudoa septempunctata
por: Shin, Sang Phil, et al.
Publicado: (2020)

Epigallocatechin-3-Gallate Reduces Neuronal Apoptosis in Rats after Middle Cerebral Artery Occlusion Injury via PI3K/AKT/eNOS Signaling Pathway
por: Nan, Wang, et al.
Publicado: (2018)

Reduction of 3-Deoxyglucosone by Epigallocatechin Gallate Results Partially from an Addition Reaction: The Possible Mechanism of Decreased 5-Hydroxymethylfurfural in Epigallocatechin Gallate-Treated Black Garlic
por: Tu, An-Ting, et al.
Publicado: (2021)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

An epigallocatechin gallate–amorphous calcium phosphate nanocomposite for caries prevention and demineralized enamel restoration
por: Dai, Danni, et al.
Publicado: (2023)

Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
por: Gim, Sang-A, et al.
Publicado: (2013)

Effects of Epigallocatechin Gallate on the Stability of Epicatechin in a Photolytic Process
por: Huang, Shiuh-Tsuen, et al.
Publicado: (2019)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

Cerebral Cortex Apoptosis in Early Aged Hypertension: Effects of Epigallocatechin-3-Gallate
por: Hsieh, Min-Huang, et al.
Publicado: (2021)

Reduction in promotor methylation utilizing EGCG (epigallocatechin-3-gallate) restores RXRα expression in human colon cancer cells
por: Morris, Jay, et al.
Publicado: (2016)

Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers
por: Huang, Yun-Ju, et al.
Publicado: (2020)

Lipopolysaccharide induces neuroglia activation and NF-κB activation in cerebral cortex of adult mice
por: Kang, Ju-Bin, et al.
Publicado: (2019)

Epigallocatechine-3-gallate Inhibits the Adipogenesis of Human Mesenchymal Stem Cells via the Regulation of Protein Phosphatase-2A and Myosin Phosphatase
por: Bécsi, Bálint, et al.
Publicado: (2022)

Ferulic Acid Attenuates the Injury-Induced Decrease of Protein Phosphatase 2A Subunit B in Ischemic Brain Injury
por: Koh, Phil-Ok
Publicado: (2013)

Chlorogenic acid alleviates the reduction of Akt and Bad phosphorylation and of phospho-Bad and 14-3-3 binding in an animal model of stroke
por: Shah, Murad-Ali, et al.
Publicado: (2022)

Antithrombotic effect of epigallocatechin gallate on the patency of arterial microvascular anastomoses
por: İğde, Murat, et al.
Publicado: (2019)

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)

Food-Grade Encapsulation Systems for (−)-Epigallocatechin Gallate
por: Shi, Meng, et al.
Publicado: (2018)

Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
por: Granja, Andreia, et al.
Publicado: (2017)

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021)

Pathological Comparisons of the Hippocampal Changes in the Transient and Permanent Middle Cerebral Artery Occlusion Rat Models
por: Shah, Fawad Ali, et al.
Publicado: (2019)

Ischemic brain injury decreases dynamin-like protein 1 expression in a middle cerebral artery occlusion animal model and glutamate-exposed HT22 cells
por: Jang, Ah-Ram, et al.
Publicado: (2016)

Baicalin attenuates lipopolysaccharide-induced neuroinflammation in cerebral cortex of mice via inhibiting nuclear factor kappa B (NF-κB) activation
por: SHAH, Murad-Ali, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_561nlcp029hdkdmpcs822sqndi